These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30095771)

  • 41. Are Health Plan Design and Prior Use of Long-Acting Reversible Contraception Associated with Pregnancy Intention?
    Armstrong MA; Postlethwaite DA; Darbinian JA; McCoy M; Law A
    J Womens Health (Larchmt); 2017 May; 26(5):450-460. PubMed ID: 27753522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postabortion Initiation of Long-Acting Reversible Contraception by Adolescent and Nulliparous Women in New Zealand.
    Rose SB; Garrett SM
    J Adolesc Health; 2016 Feb; 58(2):160-6. PubMed ID: 26603946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disparities in diabetes management among medicaid recipients with intellectual and developmental disabilities (IDD): Evidence from five U.S. states.
    Lu Z; Cogan L; McDermott S; Lauer E; Lindner S; Tracy K; Momany ET
    Disabil Health J; 2020 Apr; 13(2):100880. PubMed ID: 31870791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial.
    Rocca CH; Thompson KM; Goodman S; Westhoff CL; Harper CC
    Am J Obstet Gynecol; 2016 Jun; 214(6):716.e1-8. PubMed ID: 26692178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promotion of Long-Acting Reversible Contraception Among Adolescents and Young Adults.
    Santibenchakul S; Tschann M; Carlson ADP; L Hurwitz E; Salcedo J
    J Midwifery Womens Health; 2019 Mar; 64(2):194-200. PubMed ID: 30570219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Who uses long-acting reversible contraception? Profile of LARC users in the CUPID cohort.
    Coombe J; Harris ML; Loxton D
    Sex Reprod Healthc; 2017 Mar; 11():19-24. PubMed ID: 28159123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid repeat pregnancy among women with intellectual and developmental disabilities: a population-based cohort study.
    Brown HK; Ray JG; Liu N; Lunsky Y; Vigod SN
    CMAJ; 2018 Aug; 190(32):E949-E956. PubMed ID: 30104188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Acting Reversible Contraceptive Uptake before and after the Affordable Care Act Contraceptive Mandate in Women Undergoing First Trimester Surgical Abortion.
    Bell KN; Meyn LA; Chen BA
    Womens Health Issues; 2018; 28(4):301-305. PubMed ID: 29853173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
    Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
    Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database.
    Agostini A; Godard C; Laurendeau C; Benmahmoud Zoubir A; Lafuma A; Lévy-Bachelot L; Gourmelen J; Linet T
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):421-426. PubMed ID: 30499732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of clinical performance measures for contraceptive care in Iowa, 2013.
    Frederiksen BN; Kane DJ; Rivera M; Wheeler D; Gavin L
    Contraception; 2017 Sep; 96(3):158-165. PubMed ID: 28578146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impairment Types and Combinations Among Adolescents and Young Adults with Disabilities: Colorado 2014-2018.
    Chien AT; Spence SJ; Okumura MJ; Lu S; Chan CH; Houtrow AJ; Kuo DZ; Van Cleave JM; Shanske SA; Schuster MA; Kuhlthau KA; Toomey SL
    Acad Pediatr; 2024; 24(4):587-595. PubMed ID: 37925071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period.
    Zerden ML; Tang JH; Stuart GS; Norton DR; Verbiest SB; Brody S
    Womens Health Issues; 2015; 25(6):616-21. PubMed ID: 26212318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing the provision of long-acting reversible contraception in California.
    Biggs MA; Harper CC; Malvin J; Brindis CD
    Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Motivational Interviewing to Promote Long-Acting Reversible Contraception in Postpartum Teenagers.
    Tomlin K; Bambulas T; Sutton M; Pazdernik V; Coonrod DV
    J Pediatr Adolesc Gynecol; 2017 Jun; 30(3):383-388. PubMed ID: 27871919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How do women and health care professionals view hormonal long-acting reversible contraception? Results from an international survey.
    Faustmann T; Crocker J; Moeller C; Engler Y; Caetano C; Buhling KJ
    Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):422-429. PubMed ID: 31559869
    [No Abstract]   [Full Text] [Related]  

  • 59. Prescription contraception use and adherence by women with substance use disorders.
    Griffith G; Kumaraswami T; Chrysanthopoulou SA; Mattocks KM; Clark RE
    Addiction; 2017 Sep; 112(9):1638-1646. PubMed ID: 28387979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sexually Transmitted Infection Prevention With Long-Acting Reversible Contraception: Factors Associated With Dual Use.
    Thompson EL; Vamos CA; Griner SB; Logan R; Vázquez-Otero C; Daley EM
    Sex Transm Dis; 2017 Jul; 44(7):423-427. PubMed ID: 28608792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.